Individualizing cardiac care, the field of Cardiac Personalized Medicine is at the forefront of transforming cardiovascular treatment paradigms. This innovative approach tailors medical interventions for heart health based on an individual's distinct genetic composition, lifestyle, and specific cardiac conditions. By embracing cutting-edge technologies, including genetics, biomarkers, and diagnostics, Cardiac Personalized Medicine aims to redefine how we approach prevention, diagnosis, and treatment of cardiovascular diseases. The personalized aspect extends beyond genetics, considering lifestyle factors and patient-specific cardiac nuances. The potential impact of Cardiac Personalized Medicine is profound, as it strives to not only enhance treatment precision but also to create a more patient-centered cardiovascular healthcare landscape. As advancements in research and technology persist, the evolution of personalized medicine promises to be a key driver in optimizing cardiac care outcomes.
Title : Revolutionizing CKD care: How finerenone transforms outcomes in heart and kidney health - Insights from fidelio-DKD
Robert J Chilton, University of Texas Health Science Center San Antonio, United States
Title : Novel important cellular responses, signaling mechanisms and therapeutic options for pulmonary hypertension and right heart failure
Yong Xiao Wang, Albany Medical Center, United States
Title : Preventing sports-related cardiac arrest: Coronary artery calcium scoring stratifies the benefit of low-dose aspirin use for risk reduction
Arthur J Siegel, Massachusetts General Hospital, United States
Title : TED2HOME - A low cost automatic external defibrillator for home/office
Abraham Teddy Weiss, Hadassah University Hospital, Israel
Title : Subclinical atherosclerosis: Association with additional risk factors and somatic diseases
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain